Crossref
Hydroxychloroquine Vs Placebo for Treatment in Hospitalized Patients with COVID-19: A Randomized Controlled Double-Blind Trial in a Single Center in Brazil
JAAA · 01.12.2024 · 1 (1)
DOI: 10.17303/jaaa.2024.1.101 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAAA, online erschienen am 04.12.2024. Verfasst von Thaís Guimarães.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Guimarães, T. (2024). Hydroxychloroquine Vs Placebo for Treatment in Hospitalized Patients with COVID-19: A Randomized Controlled Double-Blind Trial in a Single Center in Brazil. JAAA, 1(1). https://doi.org/10.17303/jaaa.2024.1.101
Vancouver
Guimarães T. Hydroxychloroquine Vs Placebo for Treatment in Hospitalized Patients with COVID-19: A Randomized Controlled Double-Blind Trial in a Single Center in Brazil. JAAA. 2024;1(1). doi:10.17303/jaaa.2024.1.101
BibTeX
@article{Guimares2024,
author = {Guimarães, Thaís},
title = {Hydroxychloroquine Vs Placebo for Treatment in Hospitalized Patients with COVID-19: A Randomized Controlled Double-Blind Trial in a Single Center in Brazil},
journal = {JAAA},
year = {2024},
volume = {1},
number = {1},
doi = {10.17303/jaaa.2024.1.101}
}
EUVIMED